MEDCO HEALTH SOLUTIONS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 59 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-07-21: Reporting owner Kornwasser Laizer; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-07-21: Reporting owner SMITH JACK ALLEN; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-07-21: Reporting owner PRINCIVALLE KARIN; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-07-21: Reporting owner WENTWORTH TIMOTHY C; Form 4; Security Stock Option; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-07-21 | Kornwasser Laizer Officer (SVP-Retail, Mail & Diabetes) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −22,962 22,962 owned after | $40.58 exercise price | 2011-07-22 | |
| 2011-07-21 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,000 0 owned after | $29.24 exercise price | 2011-07-22 | |
| 2011-07-21 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,380 32,760 owned after | $63.24 exercise price | 2011-07-22 | |
| 2011-07-21 | WENTWORTH TIMOTHY C Officer (Group Pres, Employer Accounts) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,995 36,995 owned after | $40.58 exercise price | 2011-07-22 | |
| 2011-07-21 | Moriarty Thomas M Officer (Gen'l Counsel & Secretary, SVP) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −33,678 33,679 owned after | $40.58 exercise price | 2011-07-22 | |
| 2011-07-21 | DRISCOLL JOHN PATRICK Officer (President - New Markets) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −33,167 33,167 owned after | $40.58 exercise price | 2011-07-22 | |
| 2011-05-24 | POTTER MYRTLE S Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,600 6,600 owned after | $63.41 exercise price | 2011-05-26 | |
| 2011-05-24 | ROPER WILLIAM L Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,600 6,600 owned after | $63.41 exercise price | 2011-05-26 | |
| 2011-05-24 | STEVENS DAVID D Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,600 6,600 owned after | $63.41 exercise price | 2011-05-26 | |
| 2011-05-24 | GOLDSTEIN MICHAEL Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,600 6,600 owned after | $63.41 exercise price | 2011-05-26 | |
| 2011-05-24 | CASSIS JOHN L Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,600 6,600 owned after | $63.41 exercise price | 2011-05-26 | |
| 2011-05-24 | WILSON BLENDA J Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,600 6,600 owned after | $63.41 exercise price | 2011-05-26 | |
| 2011-05-24 | BARKER HOWARD W JR Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,600 6,600 owned after | $63.41 exercise price | 2011-05-26 | |
| 2011-05-24 | LILLIS CHARLES M Director | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,600 6,600 owned after | $63.41 exercise price | 2011-05-26 | |
| 2011-05-03 holding as of filing | SHEEHY FRANK J Officer (Pres. Accredo Health Group, I) | 3 | Stock Option Derivative · Direct | Holding | $33.70 exercise price | 2011-05-03 | ||
| 2011-05-03 holding as of filing | SHEEHY FRANK J Officer (Pres. Accredo Health Group, I) | 3 | Stock Option Derivative · Direct | Holding | $40.58 exercise price | 2011-05-03 | ||
| 2011-05-03 holding as of filing | SHEEHY FRANK J Officer (Pres. Accredo Health Group, I) | 3 | Stock Option Derivative · Direct | Holding | $50.35 exercise price | 2011-05-03 | ||
| 2011-05-03 holding as of filing | SHEEHY FRANK J Officer (Pres. Accredo Health Group, I) | 3 | Stock Option Derivative · Direct | Holding | $62.63 exercise price | 2011-05-03 | ||
| 2011-05-03 holding as of filing | SHEEHY FRANK J Officer (Pres. Accredo Health Group, I) | 3 | Stock Option Derivative · Direct | Holding | $63.24 exercise price | 2011-05-03 | ||
| 2011-05-02 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −47,210 0 owned after | $50.35 exercise price | 2011-05-03 | |
| 2011-05-02 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −37,760 18,880 owned after | $40.58 exercise price | 2011-05-03 | |
| 2011-05-02 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,400 0 owned after | $42.73 exercise price | 2011-05-03 | |
| 2011-03-01 | DRISCOLL JOHN PATRICK Officer (President - New Markets) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −33,166 66,334 owned after | $40.58 exercise price | 2011-03-02 | |
| 2011-03-01 | Kornwasser Laizer Officer (SVP-Retail, Mail & Diabetes) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −22,361 45,924 owned after | $40.58 exercise price | 2011-03-02 | |
| 2011-03-01 | FITZPATRICK STEVEN R Officer (Pres, Accredo Health, Inc.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −504 0 owned after | $28.17 exercise price | 2011-03-02 | |
| 2011-03-01 | FITZPATRICK STEVEN R Officer (Pres, Accredo Health, Inc.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,567 0 owned after | $25.80 exercise price | 2011-03-02 | |
| 2011-02-28 | Kornwasser Laizer Officer (SVP-Retail, Mail & Diabetes) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −600 68,285 owned after | $40.58 exercise price | 2011-03-02 | |
| 2011-02-28 | FITZPATRICK STEVEN R Officer (Pres, Accredo Health, Inc.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,120 4,560 owned after | $50.35 exercise price | 2011-03-02 | |
| 2011-02-28 | FITZPATRICK STEVEN R Officer (Pres, Accredo Health, Inc.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −22,020 0 owned after | $33.70 exercise price | 2011-03-02 | |
| 2011-02-28 | FITZPATRICK STEVEN R Officer (Pres, Accredo Health, Inc.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,550 23,950 owned after | $28.17 exercise price | 2011-03-02 | |
| 2011-02-28 | FITZPATRICK STEVEN R Officer (Pres, Accredo Health, Inc.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −23,446 504 owned after | $28.17 exercise price | 2011-03-02 | |
| 2011-02-28 | FITZPATRICK STEVEN R Officer (Pres, Accredo Health, Inc.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,673 13,347 owned after | $40.58 exercise price | 2011-03-02 | |
| 2011-02-28 | FITZPATRICK STEVEN R Officer (Pres, Accredo Health, Inc.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −23,433 16,567 owned after | $25.80 exercise price | 2011-03-02 | |
| 2011-02-28 | FITZPATRICK STEVEN R Officer (Pres, Accredo Health, Inc.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,712 15,822 owned after | $27.19 exercise price | 2011-03-02 | |
| 2011-02-28 | FITZPATRICK STEVEN R Officer (Pres, Accredo Health, Inc.) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,822 0 owned after | $27.19 exercise price | 2011-03-02 | |
| 2011-02-28 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −35,220 0 owned after | $33.70 exercise price | 2011-03-01 | |
| 2011-02-28 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −600 0 owned after | $22.10 exercise price | 2011-03-01 | |
| 2011-02-28 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,000 18,000 owned after | $29.24 exercise price | 2011-03-01 | |
| 2011-02-25 | Stettin Glen D. Officer (Chief Medical Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +34,800 34,800 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +46,630 46,630 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | WENTWORTH TIMOTHY C Officer (Group Pres, Employer Accounts) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +91,350 91,350 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,550 50,550 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | DRISCOLL JOHN PATRICK Officer (President - New Markets) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +87,000 87,000 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +23,580 23,580 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | Kornwasser Laizer Officer (SVP-Retail, Mail & Diabetes) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,250 65,250 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | Moriarty Thomas M Officer (Gen'l Counsel & Secretary, SVP) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +104,400 104,400 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | TAYLOR GLENN C Officer (Group President, Health Plans) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +91,350 91,350 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | Daschner Mary Officer (Group President, Govmt PBM) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +78,300 78,300 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | GRIFFIN BRIAN T Officer (CEO, Medco Celesio BV) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +91,350 91,350 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +174,000 174,000 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | RUBINO RICHARD J Officer (SVP, Finance & CFO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +117,450 117,450 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-02-25 | SNOW DAVID B JR Director, Officer (Chairman and CEO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +575,540 575,540 owned after | $62.63 exercise price | 2011-03-01 | |
| 2011-01-13 | GRIFFIN BRIAN T Officer (CEO, Medco Celesio BV) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −44,030 0 owned after | $33.70 exercise price | 2011-01-18 | |
| 2011-01-13 | GRIFFIN BRIAN T Officer (CEO, Medco Celesio BV) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −38,340 0 owned after | $22.10 exercise price | 2011-01-18 | |
| 2011-01-13 | GRIFFIN BRIAN T Officer (CEO, Medco Celesio BV) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,228 72,457 owned after | $40.58 exercise price | 2011-01-18 | |
| 2011-01-13 | GRIFFIN BRIAN T Officer (CEO, Medco Celesio BV) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −48,960 0 owned after | $29.24 exercise price | 2011-01-18 | |
| 2011-01-13 | GRIFFIN BRIAN T Officer (CEO, Medco Celesio BV) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −38,800 0 owned after | $42.73 exercise price | 2011-01-18 | |
| 2011-01-13 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −122,400 0 owned after | $29.24 exercise price | 2011-01-18 | |
| 2011-01-03 | WILSON BLENDA J Director | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,500 8,750 owned after | $26.02 exercise price | 2011-01-05 |